Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Several reports have suggested that because isosorbide dinitrate and hydralazine have different and additive haemodynamic effects at rest in patients with chronic heart failure, these agents should be administered in combination. Some studies, however, indicate thay they are effective individually a...
Uloženo v:
| Vydáno v: | Br Heart J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
1981
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482537/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7225252/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.45.4.376 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
